Avivagen Ownership
VIVXF Stock | USD 0.0001 0.00 0.00% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Avivagen |
Avivagen Pink Sheet Ownership Analysis
The company recorded a loss per share of 0.08. Avivagen last dividend was issued on the 25th of May 2017. The entity had 1:10 split on the 25th of May 2017. Avivagen Inc., a life sciences company, focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. Avivagen Inc. was incorporated in 2005 and is headquartered in Ottawa, Canada. Avivagen is traded on OTC Exchange in the United States.The quote for Avivagen is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more information please call G Anthony at 613 702 2908 or visit https://www.avivagen.com.Currently Active Assets on Macroaxis
Other Information on Investing in Avivagen Pink Sheet
Avivagen financial ratios help investors to determine whether Avivagen Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Avivagen with respect to the benefits of owning Avivagen security.